175713-97-0

Basic information

• Product Name: 1H-Benzimidazole, 1-phenyl-2-[4-[2-(1-piperidinyl)ethoxy]phenyl]-
• CAS NO: 175713-97-0
• Molecular Formula: C26H27N3O
• Molecular Weight: 397.52
• Mol File: 175713-97-0.mol
• Article Data: 4

Chemical Properties

• CAS DataBase Reference: 1H-Benzimidazole, 1-phenyl-2-[4-[2-(1-piperidinyl)ethoxy]phenyl]-(CAS DataBase Reference)
• NIST Chemistry Reference: 1H-Benzimidazole, 1-phenyl-2-[4-[2-(1-piperidinyl)ethoxy]phenyl]-(175713-97-0)
• EPA Substance Registry System: 1H-Benzimidazole, 1-phenyl-2-[4-[2-(1-piperidinyl)ethoxy]phenyl]-(175713-97-0)

Safety Data

• Hazardous Substances Data: 175713-97-0(Hazardous Substances Data)

Upstream product

• 1932-03-2 2-(piperidin-4-yl)ethyl chloride 
• 94212-06-3 4-(1-phenyl-1H-benzo[d]imidazol-2-yl)phenol 
• 534-85-0 N-phenyl-1,2-benzenediamine 
• 2620-84-0 2-(4-methoxyphenyl)-1-phenyl-1H-benzo[d]imidazole 
• 100-07-2 4-methoxy-benzoyl chloride 

Relevant articles and documents

Methods of treating or preventing sleep apnea

This invention provides methods for the treatment or prevention of sleep apnea in a mammal which compris administering to a mammal in need thereof an effective amount of a substituted benzimidazole, or a pharmaceutically acceptable salt or solvate thereof.

METHODS FOR TREATING A PHYSIOLOGICAL DISORDER ASSOCIATED WITH BETA-AMYLOID PEPTIDE

This invention provides substituted benzimidazoles which are useful in treating or preventing conditions associated with beta-amyloid peptide. Some such conditions associated with beta-amyloid peptide include Alzheimer's Disease, Down's Symdrome and amyloidosis of the Dutch type